The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Regulation of Ferroptotic Cancer Cell Death by GPX4
Open accessAbstract
Ferroptosis is a form of nonapoptotic cell death for which key regulators remain unknown. We sought a common mediator for the lethality of 12 ferroptosis-inducing small molecules. We used targeted metabolomic profiling to discover that depletion of glutathione causes inactivation of glutathione peroxidases (GPXs) in response to one class of compounds and a chemoproteomics strategy to discover that GPX4 is directly inhibited by a second class of compounds. GPX4 overexpression and knockdown modulated the lethality of 12 ferroptosis inducers, but not of 11 compounds with other lethal mechanisms. In addition, two representative ferroptosis inducers prevented tumor growth in xenograft mouse tumor models. Sensitivity profiling in 177 cancer cell lines revealed that diffuse large B cell lymphomas and renal cell carcinomas are particularly susceptible to GPX4-regulated ferroptosis. Thus, GPX4 is an essential regulator of ferroptotic cancer cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the reduced glutathione (GSH)-dependent enzyme glutathione peroxidase 4 (GPX4)—which is directly targeted by RSL3—has emerged as the main endogenous inhibitor of ferroptosis by virtue of its ability to limit lipid peroxidation by catalyzing the GSH-dependent reduction of lipid hydroperoxides to lipid alcohols [547–550].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [548]
In the citing paper
“erastin triggers ferroptosis by (indirectly) affecting the catalytic cycle of GPX4 via a mechanism that involves the inhibition of the cystine/glutamate antiporter system xc− and consequent decrease in intracellular cysteine (which derives from cystine reduction in the cytoplasm) and GSH (which is synthesized from cysteine) [539, 548, 549, 551].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [548]
In the citing paper
“the ferroptosis-inhibiting effect of iron depletion by either chelators [539, 543, 548] or phosphorylase kinase catalytic subunit gamma 2 (PHKG2) knockdown [566]”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [548]
In the citing paper
“Among these genes, we identified known regulators of apoptosis, such as TP53, IKBIP, and factors specifically of neuronal survival, such as XIAP17–20, GDPGP121 and MAP3K123,22–24, as well as genes not previously implicated in neuronal survival, such as IGF2BP1 and IGF2BP3.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [19]
In the citing paper
“Inhibitors of this transporter have been found to deplete intracellular glutathione in cancer cells, resulting in iron-dependent accumulation of ROS and a form of cell death termed ferroptosis (Dixon et al., 2012; Dixon et al., 2014; Yang et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yang et al., 2014
In the citing paper
“Moreover, glutathione is not depleted during RSL3-induced cell death [24], supporting the presence of an alternative ferroptosis-initiating mechanism for RSL3.”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Analysis of mass spectrometry-based proteomic data from an affinity pulldown experiment ranked GPX4 (glutathione peroxidase 4, PHGPx) as the top protein target for (1S,3R)-RSL3 [24]; western blotting further confirmed binding between (1S,3R)-RSL3 and GPX4.”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Glutathione depletion causes loss of cellular antioxidant capacity, as well as inhibition of glutathione-dependent enzymes, such as glutathione peroxidases [24, 25].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Moreover, knockdown of GPX4 expression generates lipid ROS and induces ferroptosis, supporting the hypothesis that (1S, 3R)-RSL3 induces ferroptosis through inhibition of GPX4 [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“This glutathione depletion is sufficient for erastin-dependent cell death, as glutathione depletion by another reagent, buthionine sulfoxamine (BSO), also initiated ferroptosis [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Cell lysates prepared from (1S, 3R)-RSL3-treated cells could not reduce phosphatidylcholine hydroperoxides into the corresponding alcohols, demonstrating that RSL3 inhibits GPX4 enzyme activity [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“The screening assay in which erastin and RSL3 were identified later revealed ten additional compounds that induce ferroptosis [24, 26]. All but one compound (DPI2) inhibited GPX4 directly, similar to RSL3. In contrast, DPI2 depleted GSH, like erastin [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Overexpression of GPX4 suppressed cell death induced by these compounds [24], but not other lethal agents, indicating that GPX4 is a specific and robust central regulator of ferroptotic cell death, akin to BCL-2 in apoptosis.”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Indeed, a metabolite profiling assay revealed that glutathione was the most decreased cellular metabolite during erastin-induced ferroptosis [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Although erastin displayed selective lethality in engineered cells overexpressing HRASG12V , there was no consistent difference in erastin sensitivity between wild-type and mutated RAS cells.”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Tubular cells in the kidney are also particularly susceptible to ferroptosis induction by Gpx4 deletion in vivo [15], which is intriguing in light of the enhanced sensitivity of renal cell carcinoma cell lines in culture to erastin [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Moreover, RCC was found to be particularly susceptible to erastin-induced ferroptosis compared to other tissues in the NCI-60 panel, a panel of cancer cell lines derived from eight different tissues [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“In addition, the depletion of GPX4 can promote the accumulation of lipid peroxide and lipid free radicals, causing ferroptosis (Yang et al., 2014).”
From MiR-378a-3p/ SLC7A11 regulate ferroptosis in nerve injury induced by lead exposure (2022) · cites this paper as Yang et al., 2014
In the citing paper
“Lipid peroxidation is an important characteristic of ferroptosis and is strongly regulated by GPX4 and GSH (Chen et al., 2015;Yang et al., 2014).”
From MiR-378a-3p/ SLC7A11 regulate ferroptosis in nerve injury induced by lead exposure (2022) · cites this paper as Yang et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Self-citationChemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Wendel, A. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)77046-0 · Cited by 3,032
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1951 · Cited by 2,673
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 2,504
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Brigelius-Flohé, R., & Maiorino, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.020 · Cited by 1,904
Yang, W. S., & Stockwell, B. R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.02.010 · Cited by 1,876
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,027
Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1
Miao, Z., Tian, W., Ye, Y., Gu, W. J., Bao, Z., Xu, L., Sun, G., Li, C., Tu, Y., Chao, H., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04997-1 · Cited by 130
Feng, J., Wang, J., Wang, Y., Huang, X., Shao, T., Deng, X., Cao, Y., Zhou, M., & Zhao, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.898657 · Cited by 127
Zhao, T., Yu, Z., Zhou, L., Wang, X., Hui, Y., Mao, L., Fan, X., Wang, B., Zhao, X., & Sun, C. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01173-4 · Cited by 128
EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2
Wang, B., Jin, Y., Liu, J., Liu, Q., Shen, Y., Zuo, S., & Yu, Y. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102825 · Cited by 126
Wang, H., Yu, X., Liu, D., Qiao, Y., Huo, J., Pan, S., Zhou, L., Wang, R., Feng, Q., & Liu, Z. (2023) · Advanced Science · doi:10.1002/advs.202305563 · Cited by 126
LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growth
Li, Z., Hu, Y., Zheng, H., Li, M., Liu, Y., Feng, R., Li, X., Zhang, S., Tang, M., Yang, M., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01405-y · Cited by 133
Ferroptotic therapy in cancer: benefits, side effects, and risks
Diao, J., Jia, Y., Dai, E., Liu, J., Kang, R., Tang, D., Han, L., Zhong, Y., & Meng, L. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01999-9 · Cited by 135
Metabolic interplays between the tumour and the host shape the tumour macroenvironment
Altea‐Manzano, P., Decker-Farrell, A. R., Janowitz, T., & Erez, A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00786-4 · Cited by 138
Zhang, W., Dai, J., Hou, G., Liu, H., Zheng, S., Wang, X., Lin, Q., Zhang, Y., Lu, M., Gong, Y., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.042 · Cited by 125
The Role of Efferocytosis in Autoimmune Diseases
Abdolmaleki, F., Farahani, N., Hayat, S. M. G., Pirro, M., Bianconi, V., Barreto, G. E., & Sahebkar, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01645 · Cited by 129
Chen, L., Lin, Z., Liu, L., Zhang, X., Shi, W., Ge, D., & Sun, Y. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00461 · Cited by 126
Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis
Zhu, H., Klement, J. D., Lu, C., Redd, P. S., Yang, D., Smith, A. D., Poschel, D. B., Zou, J., Liu, D., Wang, P. G., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000500 · Cited by 126
Xu, R. F., Yang, J., Qian, Y., Deng, H., Wang, Z., Ma, S., Wei, Y., Yang, N., & Shen, Q. (2021) · Nanoscale Horizons · doi:10.1039/d0nh00674b · Cited by 125
Regulated cell death: discovery, features and implications for neurodegenerative diseases
Cui, J., Zhao, S., Li, Y., Zhang, D., Wang, B., Xie, J., & Wang, J. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00799-8 · Cited by 130
Wang, X., Li, H., Peng, P., Gong, Z., Huang, J. X., & Peng, H. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110148 · Cited by 129
Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis
Hendricks, J. M., Doubravsky, C. E., Wehri, E., Li, Z., Roberts, M. A., Deol, K. K., Lange, M., Lasheras-Otero, I., Momper, J. D., Dixon, S. J., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.04.007 · Cited by 129
Xue, Y., Lu, F., Chang, Z., Li, J., Gao, Y., Zhou, J., Luo, Y., Lai, Y., Cao, S., Li, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40518-0 · Cited by 133
Tsai, Y., Xia, C., & Sun, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598555 · Cited by 124
Stamenković, A., O’Hara, K. A., Nelson, D. C., Maddaford, T. G., Edel, A. L., Maddaford, G. G., Dibrov, E., Aghanoori, M., Kirshenbaum, L. A., Fernyhough, P., et al. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00237.2020 · Cited by 124
Gao, G., Xie, Z., Li, E.-W., Yuan, Y., Fu, Y., Wang, P., Zhang, X., Qiao, Y., Xu, J., Hölscher, C., et al. (2021) · Journal of Natural Medicines · doi:10.1007/s11418-021-01491-4 · Cited by 124
Sun, S., Gao, T., Pang, B., Su, X., Guo, C., Zhang, R., & Pang, Q. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04524-2 · Cited by 133
Regulatory pathways and drugs associated with ferroptosis in tumors
Wang, D., Tang, L. M., Zhang, Y., Ge, G., Jiang, X., Mo, Y., Wu, P., Deng, X., Li, L., Zuo, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04927-1 · Cited by 131
FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner
Ji, F., Fu, X.-H., Li, G., He, Q., & Qiu, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.857765 · Cited by 125
A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria
Wu, S., Mao, C., Kondiparthi, L., Poyurovsky, M. V., Olszewski, K. L., & Gan, B. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121987119 · Cited by 130
Luo, L., Huang, F., Zhong, S., Ding, R., Su, J., & Li, X. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121091 · Cited by 125
CGI1746 targets σ1R to modulate ferroptosis through mitochondria-associated membranes
Zhang, Z., Zhou, H., Gu, W., Wei, Y., Mou, S., Wang, Y., Zhang, J., & Zhong, Q. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01512-1 · Cited by 126
Huang, G., Cai, Y., Ren, M., Zhang, X., Fu, Y., Cheng, R., Wang, Y., Miao, M., Zhu, L., & Yan, T. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.09.027 · Cited by 124
Sun, Y., Qiao, Y., Liu, Y., Zhou, J., Wang, X., Zheng, H., Xu, Z., Zhang, J., Zhou, Y., Qian, L., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101977 · Cited by 123
Temozolomide Drives Ferroptosis via a DMT1-Dependent Pathway in Glioblastoma Cells
Song, Q., Peng, S., Sun, Z., Heng, X., & Zhu, X. (2021) · Yonsei Medical Journal · doi:10.3349/ymj.2021.62.9.843 · Cited by 123
Chen, H., Zhu, J., Le, Y., Pan, J., Liu, Y., Liu, Z., Wang, C., Dou, X., & Lu, D. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.153964 · Cited by 124
CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma
Wang, Z., Zhang, X., Tian, X., Yang, Y., Ma, L., Wang, J., & Yu, Y. (2021) · Oncology Reports · doi:10.3892/or.2021.8039 · Cited by 122
Li, L., Sun, S., Tan, L., Wang, Y., Wang, L., Zhang, Z., & Zhang, L. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02795 · Cited by 122
Deng, H.-F., Yue, L., Wang, N. N., Zhou, Y.-Q., Zhou, W. J., Liu, X., Ni, Y.-H., Huang, C.-S., Qiu, L., Liu, H., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.624529 · Cited by 122
Chemodynamic nanomaterials for cancer theranostics
Xin, J., Deng, C., Aras, Ö., Zhou, M., Wu, C., & An, F. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00936-y · Cited by 125
Cheng, Y., Song, Y., Chen, H., Li, Q., Gao, Y. Z., Lu, G., & Luo, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5005136 · Cited by 124
Diet, lipids, and antitumor immunity
Prendeville, H., & Lynch, L. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00781-x · Cited by 126
Coenzyme Q biochemistry and biosynthesis
Guerra, R. M., & Pagliarini, D. J. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.12.006 · Cited by 126
Ju, J., Li, X., Zhao, X., Li, F., Wang, S., Wang, K., Li, R., Zhou, L., Liang, L., Wang, Y., et al. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00927-1 · Cited by 122
Therapeutic inhibition of ferroptosis in neurodegenerative disease
Ryan, S. K., Ugalde, C. L., Rolland, A., Skidmore, J., Devos, D., & Hammond, T. R. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.07.007 · Cited by 127
Regulation of Ferroptosis in Lung Adenocarcinoma
Wei, X., Li, X., Hu, S., Cheng, J., & Cai, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914614 · Cited by 126
Ashrafizadeh, M., Mohammadinejad, R., Tavakol, S., Ahmadi, Z., Roomiani, S., & Katebi, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28740 · Cited by 122
Sun, L., Dong, H., Zhang, W., Wang, N., Ni, N., Bai, X., & Liu, N. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5730 · Cited by 121
Ferrer, M., Mourikis, N., Davidson, E. E., Kleeman, S. O., Zaccaria, M., Habel, J., Rubino, R., Gao, Q., Flint, T. R., Young, L., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.05.008 · Cited by 121
Li, X., Zou, Y. S., Xing, J., Fu, Y., Wang, K., Wan, P., & Zhai, X. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6286984 · Cited by 122
Zhao, J., Dar, H. H., Deng, Y., Croix, C. M. S., Li, Z., Minami, Y., Shrivastava, I. H., Tyurina, Y. Y., Etling, E. B., Rosenbaum, J. C., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921618117 · Cited by 121
Iron Metabolism and Ferroptosis in Epilepsy
Chen, S., Chen, Y., Zhang, Y., Kuang, X., Liu, Y., Guo, M., Ma, L., Zhang, D., & Li, Q. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.601193 · Cited by 122
Recent progress on targeting ferroptosis for cancer therapy
Xu, G., Wang, H., Li, X., Huang, R., & Luo, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114584 · Cited by 121
Yang, H., Yao, X., Liu, Y., Shen, X., Li, M., & Luo, Z. Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c04632 · Cited by 122
Detection of Ferroptosis by BODIPY™ 581/591 C11
Martinez, A. M., Kim, A., & Yang, W. S. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0247-8_11 · Cited by 119
Self-citationThe Role of Iron, Its Metabolism and Ferroptosis in Traumatic Brain Injury
Tang, S., Gao, P., Chen, H., Zhou, X., Ou, Y., & He, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.590789 · Cited by 120
Lin, X., Ouyang, S., Zhi, C., Li, P., Tan, X., Ma, W., Jiang, Y., Peng, T., Chen, X., Liang, L., et al. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109098 · Cited by 120
Microenvironmental influences on T cell immunity in cancer and inflammation
Heintzman, D. R., Fisher, E. L., & Rathmell, J. C. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00833-2 · Cited by 119
Zeng, C., Lin, J., Zhang, K., Ou, H., Shen, K., Liu, Q., Wei, Z., Dong, X., Zeng, X., Zeng, L., et al. (2022) · Cancer Science · doi:10.1111/cas.15531 · Cited by 120
Potęga, A. (2022) · Molecules · doi:10.3390/molecules27165252 · Cited by 123
Small-molecule allosteric inhibitors of GPX4
Liu, H., Forouhar, F., Lin, A. J., Wang, Q., Polychronidou, V., Soni, R. K., Xia, X., & Stockwell, B. R. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.11.003 · Cited by 120
Self-citationJiang, Y., Chen, Y., Wang, Y., Chen, X., Zhou, X., Qing, K., Cao, W., & Zhang, Y. (2023) · Water Research · doi:10.1016/j.watres.2023.120291 · Cited by 120
Zheng, X., Jin, X., Ye, F., Liu, X., Yu, B., Li, Z., Zhao, T., Chen, W., Liu, X., Di, C., et al. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00427-w · Cited by 125
Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest
Rodencal, J., Kim, N., He, A., Li, V. L., Lange, M., He, J., Tarangelo, A., Schafer, Z. T., Olzmann, J. A., Long, J. Z., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.10.011 · Cited by 120
Kose, T., Vera‐Aviles, M., Sharp, P., & Latunde-Dada, G. O. (2019) · Pharmaceuticals · doi:10.3390/ph12010026 · Cited by 119
Ferroptosis: An emerging therapeutic opportunity for cancer
Wang, L., Chen, X., & Yan, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.09.005 · Cited by 120
β-Carbolines as potential anticancer agents
Aaghaz, S., Sharma, K., Jain, R., & Kamal, Ä. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113321 · Cited by 118
Precise Chemodynamic Therapy of Cancer by Trifunctional Bacterium-Based Nanozymes
Zhang, W., Liu, J., Li, X., Zheng, Y., Chen, L., Wang, D., Foda, M. F., Ma, Z., Zhao, Y., & Han, H. (2021) · ACS Nano · doi:10.1021/acsnano.1c05605 · Cited by 118
STAT3-mediated ferroptosis is involved in ulcerative colitis
Huang, F., Zhang, S., Li, X., Huang, Y., He, S., & Luo, L. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.06.242 · Cited by 118
When ferroptosis meets pathogenic infections
Gao, J., Wang, Q., Tang, Y.-D., Zhai, J., Hu, W., & Zheng, C. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.11.006 · Cited by 118
Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.
Wang, S., Luo, J., Zhang, Z., Dong, D., Shen, Y., Fang, Y., Hu, L., Liu, M., Dai, C., Peng, S., et al. (2018) · Europe PMC (PubMed Central) · Cited by 117
Wu, P., Li, C., Ye, D. M., Yu, K., Li, Y., Tang, H., Xu, G., Yi, S., & Zhang, Z. (2021) · Aging · doi:10.18632/aging.202518 · Cited by 117
Diabetic ferroptosis plays an important role in triggering on inflammation in diabetic wound
Li, S., Li, Y., Wu, Z., Wu, Z., & Fang, H. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00042.2021 · Cited by 121
Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials
Feng, Q., Yu, X., Qiao, Y., Pan, S., Wang, R., Zheng, B., Wang, H., Ren, K., Liu, H., & Yang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.858676 · Cited by 118
Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response
Shakya, A., McKee, N. W., Dodson, M. B., Chapman, E., & Zhang, D. D. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0005 · Cited by 120
Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases
Wang, Y., Lv, M.-N., & Zhao, W. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102035 · Cited by 122
Yang, P., Li, J., Zhang, T., Ren, Y., Zhang, Q., Liu, R., Li, H., Hua, J., Wang, W., Wang, J., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01230-0 · Cited by 126
Iron Regulation of Pancreatic Beta-Cell Functions and Oxidative Stress
Backe, M. B., Moen, I. W., Ellervik, C., Hansen, J. B., & Mandrup-Poulsen, T. R. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050939 · Cited by 119
A Glutathione-Nrf2-Thioredoxin Cross-Talk Ensures Keratinocyte Survival and Efficient Wound Repair
Telorack, M., Meyer, M., Ingold, I., Conrad, M., Bloch, W., & Werner, S. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005800 · Cited by 116
(+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis
Wang, M., Liu, C., Wang, T., Yu, H.-M., Ouyang, S., Wu, Y., Gong, H., Ma, X., Jiao, G., Fu, L., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02961-5 · Cited by 116
Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT/GPx4 Axis
Zhang, Q., Qu, H., Chen, Y., Luo, X., Chen, C., Xiao, B., Ding, X., Zhao, P., Lu, Y., Chen, A. F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.806081 · Cited by 119
Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis
Pan, X., Lin, Z., Jiang, D., Yu, Y., Yang, D., Zhou, H., Zhan, D., Liu, S., Peng, G., Chen, Z., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.9888 · Cited by 117
The Potential Role of Ferroptosis in Neonatal Brain Injury
Wu, Y., Song, J., Wang, Y., Wang, X., Culmsee, C., & Zhu, C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00115 · Cited by 116
Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice
Zang, H., Wu, W., Qi, L., Tan, W., Nagarkatti, P. S., Nagarkatti, M., Wang, X., & Cui, T. (2020) · Diabetes · doi:10.2337/db19-1176 · Cited by 115
Cathepsin B is a mediator of organelle-specific initiation of ferroptosis
Kuang, F., Liu, J., Li, C., Kang, R., & Tang, D. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.035 · Cited by 115
Ferrostatin-1 alleviates angiotensin II (Ang II)- induced inflammation and ferroptosis in astrocytes
Li, S., Zhou, C., Zhu, Y., Chao, Z., Sheng, Z., Zhang, Y., & Zhao, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107179 · Cited by 115
Zhu, J., Xiong, Y., Zhang, Y., Wen, J., Cai, N., Cheng, K., Liang, H., & Zhang, W. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8810785 · Cited by 116
Fu, X.-W., & Song, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748039 · Cited by 115
Wu, C., Du, M., Yu, R., Cheng, Y., Wu, B., Fu, J., Tan, W., Zhou, Q., Balawi, E., & Liao, Z. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.12.007 · Cited by 116
Iseda, N., Itoh, S., Toshida, K., Tomiyama, T., Morinaga, A., Shimokawa, M., Shimagaki, T., Wang, H., Kurihara, T., Toshima, T., et al. (2022) · Cancer Science · doi:10.1111/cas.15378 · Cited by 117
Koeberle, S. C., Kipp, A. P., Stuppner, H., & Koeberle, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21933 · Cited by 117
Zhang, Y., Zhang, N., Xing, J., Sun, Y., Xu, J., Shen, C., Cheng, L., Wang, Y., & Wang, X. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122675 · Cited by 120
Macías‐Rodríguez, R. U., Inzaugarat, M. E., Ruiz‐Margáin, A., Nelson, L. J., Trautwein, C., & Cubero, F. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051651 · Cited by 116
Liu, Y., Zeng, L., Yang, Y., Chen, C., Wang, D. W., & Wang, H. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02948-2 · Cited by 117
Ferroptosis in a sarcopenia model of senescence accelerated mouse prone 8 (SAMP8)
Huang, Y., Wu, B., Shen, D., Chen, J., Yu, Z., & Chen, C. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.53126 · Cited by 116
xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers
Lee, N., Carlisle, A. E., Peppers, A., Park, S. J., Doshi, M. B., Spears, M. E., & Kim, D. (2021) · Antioxidants · doi:10.3390/antiox10020317 · Cited by 119
Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression
Sui, S., Xu, S., & Pang, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107992 · Cited by 117
Emerging roles of ferroptosis in cardiovascular diseases
Wang, K., Chen, X., Wang, Y.-H., Cheng, X., Zhao, Y., Zhou, L., & Wang, K. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01183-2 · Cited by 117
Yang, X., Kawasaki, N. K., Min, J., Matsui, T., & Wang, F. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.10.004 · Cited by 117
Pro-ferroptotic signaling promotes arterial aging via vascular smooth muscle cell senescence
Sun, D.-Y., Wu, W., Wu, J., Shi, Y. L., Xu, J., Ouyang, S.-X., Chi, C., Shi, Y., Ji, Q., Miao, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45823-w · Cited by 114
Stoppe, C., Averdunk, L., Goetzenich, A., Soppert, J., Marlier, A., Kraemer, S., Vieten, J., Coburn, M., Kowark, A., Kim, B., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4886 · Cited by 113
The Emerging Roles of Ferroptosis in Huntington’s Disease
Mi, Y., Gao, X., Xu, H., Cui, Y., Zhang, Y., & Gou, X. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8518-6 · Cited by 115
Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro
Homma, T., Kobayashi, S., Sato, H., & Fujii, J. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111592 · Cited by 113
Zhu, G., Murshed, A., Li, H., Ma, J., Zhen, N., Ding, M., Zhu, J., Mao, S., Tang, X., Liu, L., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00468-2 · Cited by 113
Toyokuni, S. (2016) · Pathology International · doi:10.1111/pin.12396 · Cited by 111
The Roles of Coenzyme Q in Disease: Direct and Indirect Involvement in Cellular Functions
Pallotti, F., Bergamini, C., Lamperti, C., & Fato, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010128 · Cited by 109
Metadata
- Authors
- Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., Brown, L. M., Girotti, A. W., Cornish, V. W., Schreiber, S. L., & Stockwell, B. R.
- Affiliations
- Columbia University (US)
- Broad Institute (US)
- Medical College of Wisconsin (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Stockwell, Brent R.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 156
- Issue
- 1-2
- Pages
- 317-331
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4076414
- OpenAlex
- W2002490399
- Cited by
- 7,713
- References
- 48
- Citations by year
- 2026: 1070 · 2025: 1226 · 2024: 1343 · 2023: 1164 · 2022: 1041 · 2021: 759 · 2020: 421 · 2019: 256 · 2018: 151 · 2017: 115 · 2016: 86 · 2015: 53 · 2014: 25
- FWCI
- 74.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation (CHE 0840451)
- New York State Stem Cell Science (C026715)
- Empire State Development's Division of Science, Technology and Innovation
- Arnold and Mabel Beckman Foundation
- National Institutes of Health (R01CA161061, 5R01CA097061, 5R01GM085081, 1S10RR025431-01A1)
- Broad Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- ferroptosis, GPX4, glutathione peroxidase, glutathione depletion, ferroptosis inducers, non-apoptotic cell death, cancer cell death, chemoproteomics, targeted metabolomics, diffuse large B-cell lymphoma, renal cell carcinoma, tumor growth inhibition
- MeSH terms
- Phospholipid Hydroperoxide Glutathione Peroxidase, Animals, Carbolines, Carcinoma, Renal Cell, Glutathione, Glutathione Peroxidase, Humans, Neoplasm Transplantation, Neoplasms, Piperazines, Lymphoma, B-Cell, Cell Death, Cell Line, Tumor, Mice, Gene Knockdown Techniques, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
